Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.100
+0.020 (1.85%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $34.59 million as of October 9, 2026. It is the 33,172nd most valuable company in the world and the 4,917th biggest in the United States. Its market cap has decreased by 27.95% in one year.
Market Cap
34.59M
Enterprise Value
-546.42K
1-Year Change
-27.95%
Global Rank
Country Rank
#4,917 United States
Category
ChartMarket Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $34.59M, an increase of 107.10%. That is a compound annual growth rate of 5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 34.60M | -18.40% |
| Dec 31, 2025 | 42.40M | 7.89% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
| Dec 27, 2012 | 16.70M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 38.75M |
| Metagenomi Therapeutics | 37.56M |
| Impact BioMedical | 36.27M |
| Lite Strategy | 36.03M |
| CEL-SCI | 35.27M |
| Aligos Therapeutics | 34.47M |
| BriaCell Therapeutics | 34.15M |
| NanoViricides | 33.69M |